Medeor Pharma Profile
Key Indicators
- Authorised Capital ₹ 4.30 M
as on 17-07-2024
- Paid Up Capital ₹ 4.27 M
as on 17-07-2024
- Company Age 41 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.58 Cr
as on 17-07-2024
- Satisfied Charges ₹ 9.30 M
as on 17-07-2024
- Revenue 7.02%
(FY 2023)
- Profit 1593.86%
(FY 2023)
- Ebitda 24.69%
(FY 2023)
- Net Worth 1.83%
(FY 2023)
- Total Assets -19.83%
(FY 2023)
About Medeor Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.30 M and a paid-up capital of Rs 4.27 M.
The company currently has active open charges totaling ₹2.58 Cr. The company has closed loans amounting to ₹9.30 M, as per Ministry of Corporate Affairs (MCA) records.
Arup Das, Bibek Roy, Tarun Banerjee, and One other member serve as directors at the Company.
- CIN/LLPIN
U51909WB1983PTC035981
- Company No.
035981
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Mar 1983
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Medeor Pharma?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arup Das  | Director | 16-Dec-1996 | Current |
| Bibek Roy | Director | 24-Dec-1996 | Current |
| Tarun Banerjee | Director | 26-Jun-2014 | Current |
| Jonaki Banerjee | Director | 30-Nov-2015 | Current |
Financial Performance of Medeor Pharma.
Medeor Pharma Pvt Ltd, for the financial year ended 2023, experienced modest growth in revenue, with a 7.02% increase. The company also saw a substantial improvement in profitability, with a 1593.86% increase in profit. The company's net worth moved up by a moderate rise of 1.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medeor Pharma?
In 2023, Medeor Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bimala Engineering Construction Private LimitedActive 16 years 6 monthsTarun Banerjee and Jonaki Banerjee are mutual person
Charges (Loans)
₹25.85 M
₹9.30 M
Charges Breakdown by Lending Institutions
- Indian Bank : 2.49 Cr
- State Bank Of India : 0.09 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Sep 2010 | Indian Bank | ₹2.49 Cr | Open |
| 17 Mar 2005 | State Bank Of India | ₹0.90 M | Open |
| 20 Apr 2007 | Punjab National Bank | ₹0.30 M | Satisfied |
| 31 Mar 2006 | Punjab National Bank | ₹7.00 M | Satisfied |
| 31 Mar 2006 | Punjab National Bank | ₹2.00 M | Satisfied |
How Many Employees Work at Medeor Pharma?
Medeor Pharma has a workforce of 22 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medeor Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medeor Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
